Rifampin recalls

Rifampin products have been recalled 7 times, most recently on 7 Feb 2024. The recalling company is usually Lupin Pharmaceuticals. The most common reason is potency & assay.

Total recalls7since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 7 Feb 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 7 100%Class III 0 0%

Why rifampin is recalled

Potency & Assay686%
Nitrosamine Impurity114%

Companies

Product types

Injectable & IV Drugs343%

By year

2024229%
2023114%
2022229%
2019114%
2015114%

All rifampin recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
7 Feb 2024Drug	CLASS II	Rifampin Capsules USP 300mg recalled by Lupin PharmaceuticalsRifampin	Lupin Pharmaceuticals	Potency & Assay	MD
7 Feb 2024Drug	CLASS II	Rifampin Capsules USP 150mg recalled by Lupin PharmaceuticalsRifampin	Lupin Pharmaceuticals	Potency & Assay	MD
18 Jan 2023Drug	CLASS II	Rifampin Capsules USP, 300 mg recalled by Lupin PharmaceuticalsRifampin	Lupin Pharmaceuticals	Potency & Assay	Nationwide
24 Aug 2022Drug	CLASS II	Rifampin Capsules, USP, 150 mg HDPE recalled by Lupin PharmaceuticalsRifampin	Lupin Pharmaceuticals	Nitrosamine Impurity	Nationwide
27 Apr 2022Drug	CLASS II	Rifampin for Injection, USP, 600 mg/vial, One Vial recalledRifampin	Mylan Pharmaceuticals	Potency & Assay	Nationwide
16 Oct 2019Drug	CLASS II	Rifampin for Injection, USP, 600 mg/vial recalledRifampin	Mylan Laboratories Limited (Sterile Products Division)	Potency & Assay	Nationwide
22 Jul 2015Drug	CLASS II	Rifampin for Injection, USP 600mg/vial in a vial recalledRifampin	Fresenius Kabi USA	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.